MedTrace Logo

VIA Disc NP Pilot for Patients With Symptomatic Degenerated Discs

NCT05201287 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-04-29

No results posted yet for this study

Summary

VIA Disc NP is an allograft intended to supplement the nucleus pulposus tissue in degenerated intervertebral discs.

Conditions

  • Degenerative Disc Disease
  • Low Back Pain
  • Disc Degeneration

Interventions

OTHER

VIA Disc NP

VIA Disc NP is processed from donated cadaveric disc tissue, lyophilized, and micronized to particles.

Sponsors & Collaborators

  • MCRA

    collaborator INDUSTRY

  • VIVEX Biologics, Inc.

    lead INDUSTRY

Principal Investigators

  • Douglas Beall, MD · Clinical Radiology of Oklahoma

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-30
Primary Completion
2023-01-05
Completion
2024-12-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05201287 on ClinicalTrials.gov